logo-white

Abacus Medicine Pharma Services and Laboratoires CTRS extend partnership to improve access to Orphacol® in Spain

CTRS and Abacus Medicine Pharma Services

Abacus Medicine Pharma Services and Laboratoires CTRS extend partnership to improve access to Orphacol® in Spain PRESS RELEASE Abacus Medicine Pharma Services (AMPS) and Laboratoires CTRS, marketing authorization holder of Orphacol®, are proud to announce a strategic partnership that ensures continuous stock of Orphacol® in Spain. Furthermore, the partnership means improved delivery lead times for […]

Abacus Medicine Pharma Services and AddMedica sign partnership agreement for the distribution of Siklos® in Benelux

AddMedica and Abacus Medicine Pharma Services

Abacus Medicine Pharma Services and AddMedica sign partnership agreement for the distribution of Siklos® in Benelux Abacus Medicine Pharma Services (AMPS) and AddMedica are proud to announce the signing of a partnership agreement for the marketing and distribution of Siklos® in Benelux. PRESS RELEASE Siklos® 100mg and 1000mg film-coated tablets are indicated for the treatment […]

Abacus Medicine Pharma Services and Gen.Orph sign partnership agreement for the exclusive distribution of Miglustat Gen.Orph in Austria

Gen. Orph and Abacus Medicine Pharma Services sign partnership agreement

Abacus Medicine Pharma Services and Gen.Orph sign partnership agreement for the exclusive distribution of Miglustat Gen.Orph in Austria. Abacus Medicine Pharma Services (AMPS) and Gen.Orph are proud to announce the signing of a partnership agreement for the exclusive marketing and distribution of Miglustat Gen.Orph in Austria. PRESS RELEASE Miglustat Gen.Orph 100 mg hard capsules is […]

Abacus Medicine Pharma Services and Luye Pharma sign distribution agreement for Named Patient Program (NPP) of Lurbinectedin in Hong Kong

Abacus-Medicine-Pharma-Services-and-Luye-Pharma

Abacus Medicine Pharma Services and Luye Pharma sign distribution agreement for Named Patient Program (NPP) of Lurbinectedin in Hong Kong. Abacus Medicine Pharma Services (AMPS) and Luye Pharma Group are proud to announce the signing of an exclusive distribution contract to make Lurbinectedin available to small cell lung cancer patients in Hong Kong via the […]

Webinar: Mitigating CTS costs post-COVID

Capture_CTSUSA_slide1_v2

Webinar: Mitigating CTS costs post-COVID According to information published by GlobalData, 1200 clinical trials were disrupted by COVID-19. In this webinar, Ian Hoban, Business Development Director (Clinical Trial Solutions), talks about the risks and the actions that can be implemented to avoid the “COVID Timebomb.” Simon Estcourt, Managing Director, and Warren Crawford, Corporate Development Director, […]